Mark Woodward

Mark Woodward is a Senior Scientist specializing in Drug Metabolism and Pharmacokinetics (DMPK) with extensive experience in LC-MS/MS analytical methods within pharmaceutical R&D settings. Currently at Aktis Oncology, Mark has previously held senior roles at companies such as Metabolon, LCMS Analytical Scientist, Tergus Pharma, MAKO Medical, and GSK, where responsibilities included developing and validating quantitative assays, managing teams, and leading quality improvement initiatives. Mark's career spans over 15 years in laboratory operations, method development, and client engagement, complemented by entrepreneurial experience as the founder of Qodon Consulting, LLC. Mark holds a Bachelor of Science in Biology with a minor in Chemistry from Western Carolina University.